Table II.
Group | Treatment | Fasting blood glucose (mmol/l) | 2 h postprandial blood glucose (mmol/l) | Insulin resistance | Triglyceride (mmol/l) | Total cholesterol (mmol/l) |
---|---|---|---|---|---|---|
Observation group | 1 week after treatment | 7.9±0.3 | 9.9±0.5 | 1.3±0.1 | 2.12±0.08 | 5.39±0.15 |
1 month after treatment | 5.6±0.2a,b | 7.5±0.3a,b | 1.1±0.11a,b | 1.56±0.07a,b | 3.69±0.08a,b | |
Control group | 1 week after treatment | 8.0±0.4 | 10.0±0.5 | 1.4±0.1 | 2.13±0.09 | 5.40±0.16 |
1 month after treatment | 6.5±0.3a | 8.5±0.61a | 1.3±0.11a | 1.96±0.061a | 5.23±0.101a | |
t1 | 40.345 | 26.032 | 8.944 | 33.318 | 62.129 | |
p1 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
t2 | 18.974 | 12.147 | 4.472 | 9.940 | 5.698 | |
p2 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
t3 | 15.787 | 9.428 | 8.944 | 27.440 | 76.055 | |
p3 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
P<0.05 vs. observation group and control group at 1 week after treatment
P<0.05 vs. control group at 1 week after treatment. t1, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t2, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t3, the results of comparison between observation group and control group at 1 month after treatment.